Based in Switzerland, Targeted Solutions AG (TS-AG) focuses on enhancing medication access in Low and Middle-Income Countries (LMICs).
We support LMIC pharmaceutical companies by facilitating the efficient submission of drug dossiers to top-tier regulatory agencies like the MHRA and EMA.
This process is streamlined through acquiring Marketing Authorisation, significantly accelerating the approval and market entry of essential drugs in LMICs.
Additionally, we address the challenges of medication affordability and availability in countries with high costs and supply shortages.
Our work includes strategically repurposing small molecules to broaden treatment accessibility.
Our mission includes addressing high costs and drug shortages, ensuring everyone has access to necessary healthcare.
Our goal is to achieve health equity through strategic partnerships, pioneering solutions, and a steadfast commitment to the communities we serve.
By leveraging our extensive network and expertise, we aim to overcome barriers related to cost and availability, ensuring that no patient is left without the care they need.
TS-AG is dedicated to improving global health by making essential medications accessible and affordable in Low and Middle-Income Countries (LMICs).
We empower LMIC pharmaceutical companies to expand their markets by navigating complex regulatory landscapes for faster treatment approvals.
By repurposing small molecules, we innovate within the pharmaceutical field, creating new treatment possibilities.
Targeted Solutions offers pharmaceutical companies, health authorities, and NGOs an unparalleled opportunity to make a tangible impact on global health.
Our comprehensive approach not only addresses immediate healthcare needs but also lays the groundwork for long-term sustainability and growth in the pharmaceutical sector.
At the heart of Targeted Solutions is a diverse ensemble of experts, including regulators, clinical and technical developers, marketing specialists, IP professionals, and veterans from hospitals, pharmacies, and health departments.
This multidisciplinary team is the driving force behind our innovative strategies, united in the goal of making healthcare more accessible and affordable for LMIC populations.
